Metabolic-Fit / 100
Sprout Health review
Flat pricing through every dose escalation, named partner pharmacies and a state list it actually publishes — undercut by an open FDA warning letter, an F rating at the BBB, and brand-name pens advertised on its site that you cannot buy.
then $299/mo ongoing
- HSA / FSA-eligible
- Editor-vetted
- No insurance needed
Referral link, walled off from the score
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Every clinical figure in this piece is cited inline to its primary source — the trial or the FDA label — so you can open it and check us. This is background reading, not medical advice.
Sprout Health at a glance
- Semaglutide
- $299/mo
- Tirzepatide
- $349/mo
- Coverage
- 44 states (not AL, AR, CA, LA, MS, ND)
- Brand-name
- Compounded only
How we scored Sprout Health
Each factor is scored from Sprout Health's real pricing, disclosures and oversight, then combined into the 61/100 Metabolic-Fit Score by the same weighted six-factor framework we apply to every provider — never nudged by whether a provider pays us.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Limited public detail on who oversees care and how.
Cost is unpredictable or sits at the premium end.
Support is thin once the prescription ships.
Complaints cluster around billing lock-in and hard cancellation.
How we verified this review
- Last verified
- July 2026
- Confidence
- high
- Primary source
- joinsprouthealth.com/start-weightloss
Operating entity is Sprout Health Partners LLC (Encinitas, CA; its own terms misspell it 'Sprouth'). Standing prices are stated in its own FAQ at joinsprouthealth.com/start-weightloss/: '$299/month for Compounded Semaglutide and $349/month for Compounded Tirzepatide'. These were separately confirmed against the live checkout and the site's public store API, which agree — so the widely repeated '$149/mo' is a teaser, not a price. Flat dose pricing is stated verbatim: the payment 'will never increase … EVEN IF your dosage increases'. Prepay tiers run $205/$250 (3-month) and $169/$229 (6-month) per month. State list read verbatim from terms §30: 44 states, excluding AL, AR, CA, LA, MS, ND (DC in neither list) — though the intake quiz accepted California without blocking, and a separate page claims '5000+ patients in 50 states'. brandAccess is FALSE deliberately: Wegovy® and Zepbound® are advertised between $1,249 and $1,999 but cannot be bought — every CTA routes to the same compounded-only checkout and no brand product exists in the catalogue. REGULATORY: an FDA warning letter (MARCS-CMS 715879, 9 September 2025) to 'Sprout Health Partners LLC dba Sprout Health' over the claim that 'GLP-1 medications are FDA-approved', cited as misbranding under FDCA §§ 502(a) and 502(bb); FDA's index shows no response and no close-out. BBB rates it F with 64 complaints, 32 unanswered. Two contradictory refund policies are live simultaneously on its two domains. NOT VERIFIED: litigation, FTC action and state-attorney-general history were not searchable within this session's budget — absence of a finding here is not evidence of absence.
What to expect when you sign up
We walked Sprout Health's public signup funnel (July 2026) — a first-hand look at the flow. We don't create accounts, enter medical data, or complete checkout, so this is what any visitor sees, not a patient outcome.
- 1Land on one of many quiz landers — the sitemap carries separate pages per traffic source, including /quiz-weightloss-forbes/ and /quiz-weightloss-webmd/ — each leading with a different teaser price
- 2Brand-name pens are advertised alongside them: Wegovy® at $1,579 on one homepage and $1,799 on the other, Zepbound® at $1,249 and $1,999
- 3Answer goal, sex assigned at birth, age band and state, then height and weight; no price is shown at any quiz step, only a promo-code banner
- 4You are charged BEFORE the medical review — the site states so plainly — and the detailed medical questionnaire comes after purchase
What we noticed
- The advertised brand-name pricing is not purchasable — every call to action resolves to the same compounded-only checkout, and no brand product exists in the catalogue
- The headline $99/$149 figures are first-month promotional rates; the program price stated in its own FAQ is $299 and $349
- At least four different first-month promotions run simultaneously across its pages ($99 first month, $150 off with FIRST150, $200 off with WELCOME200, $250 off) — the same product at four different entry prices depending on which lander you arrive on
- Pricing is flat across dose escalations, stated verbatim: the monthly payment 'will never increase … EVEN IF your dosage increases in subsequent months'
- The terms publish an explicit state list — 44 states, excluding Alabama, Arkansas, California, Louisiana, Mississippi and North Dakota — but the intake quiz accepted California without blocking
- Two partner compounding pharmacies are named (Foothills Pharmacy and Promise Pharmacy), as is the clinician network, MD Integrations; no medical director is named anywhere
- The 'Excellent 4.9' rating shown on its landers is a hardcoded image, not a live review widget; its actual Trustpilot score is 3.7 across 122 reviews
Pricing
Prices re-verified
| Medication | Plan | Monthly |
|---|---|---|
| Compounded semaglutide | Monthly plan (flat, all doses)$99 the first month with code WELCOME200 (monthly plan only), then $299/mo flat through every dose escalation. | $99 → $299 |
| Compounded tirzepatide | Monthly plan (flat, all doses)$149 the first month with code WELCOME200, then $349/mo flat through every dose escalation. | $149 → $349 |
| Compounded semaglutide | 3-month planPer-month rate on the 3-month prepay tier ($615 for a three-month supply, discounted to $465 at times). | $205 |
| Compounded tirzepatide | 3-month planPer-month rate on the 3-month prepay tier ($750 for a three-month supply, discounted to $600 at times). | $250 |
| Compounded semaglutide | 6-month planPer-month rate on the 6-month prepay tier — the lowest figure available, and the longest lock-in. | $169 |
| Compounded tirzepatide | 6-month planPer-month rate on the 6-month prepay tier. | $229 |
HSA/FSA is commonly accepted for GLP-1 telehealth — check your plan. Prices reflect Sprout Health's public disclosures at last review and change often; confirm the current number on Sprout Health's own site.
What we like
- Flat pricing through every dose escalation, stated explicitly — the bill does not climb as you titrate up
- Names its two partner compounding pharmacies and its clinician network, which is more disclosure than much of this market offers
- Publishes an explicit 44-state list in its terms rather than leaving coverage vague
- Offers a sublingual option for anyone who wants to avoid injections, and 3- and 6-month tiers that cut the monthly rate
- A staffed support phone line with published weekday hours
The caveats
- Carries an FDA warning letter (MARCS-CMS 715879, issued 9 September 2025) over marketing that described GLP-1 medications as FDA-approved; FDA's index records no response and no close-out
- Rated F by the Better Business Bureau, with 64 complaints on file and 32 of them unanswered
- Advertises Wegovy® and Zepbound® between roughly $1,249 and $1,999, but they are not purchasable — every call to action routes to the same compounded-only checkout
- You are charged before the medical review; the detailed medical questionnaire comes after purchase
- Two contradictory refund policies are live at once — its main site promises staged refunds minus a $50 clinical-review fee, its landing-page domain says all prescription medications are non-refundable
- The $99/$149 headline figures are first-month promotional rates; the program price in its own FAQ is $299/$349, and at least four different intro offers run simultaneously
- Not available in Alabama, Arkansas, California, Louisiana, Mississippi or North Dakota — though the intake quiz accepted California without blocking
- The 'Excellent 4.9' rating on its landers is a hardcoded image; the live Trustpilot score is 3.7
- No medical director is named, no lab work is mentioned anywhere, and there is no postpartum, breastfeeding or PCOS material of any kind
Sprout Health for mothers: our verdict
Flat pricing through every dose escalation, named partner pharmacies and a state list it actually publishes — undercut by an open FDA warning letter, an F rating at the BBB, and brand-name pens advertised on its site that you cannot buy. The advertised entry is $99, but the standing rate settles near $299/month — so read the headline as a starting offer, not the monthly cost.
We weigh Sprout Health the way mothers actually have to: not just the monthly cost, but postpartum and breastfeeding timing and PCOS and insulin resistance — the parts a generic weight-loss review skips.
What Sprout Health actually costs
- Compounded semaglutide — Monthly plan (flat, all doses): $99 to start, then $299/mo
- Compounded tirzepatide — Monthly plan (flat, all doses): $149 to start, then $349/mo
- Compounded semaglutide — 3-month plan: $205/mo
- Compounded tirzepatide — 3-month plan: $250/mo
- Compounded semaglutide — 6-month plan: $169/mo
- Compounded tirzepatide — 6-month plan: $229/mo
For context, the typical ongoing price across our roster is around $199/month, so Sprout Health sits at the premium end.
The medications Sprout Health prescribes
Sprout Health prescribes semaglutide and tirzepatide — the two molecules with the strongest published weight-loss outcomes, and having both on one account matters when insulin resistance (common with PCOS and after gestational diabetes) makes tirzepatide the better-suited option. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.
A needle-free oral or sublingual option is on the menu, which draws in mothers who've been avoiding injections — just set expectations: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used.
Where Sprout Health fits — and where it doesn't — for mothers
A good fit if…
- you want a real clinician reading your history around postpartum and breastfeeding timing, not an auto-approving quiz.
- you may need to move between semaglutide and tirzepatide as your body and hormones change.
Look elsewhere if…
- you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
- a clean regulatory record is a dealbreaker — note the FDA warning flagged in the cons above.
- you'd rather a prescriber talk through timing around postpartum and breastfeeding timing — that's what our #1 pick, CoreAge Rx, is built for.
Trust, safety, and oversight
Our confidence in Sprout Health's public facts is high — pricing, pharmacies, and clinical network were verifiable at last review. It carries an FDA warning letter, flagged in the cons — read it before starting. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our scoring methodology.
A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.
The bottom line
Sprout Health is a provider we list only with full disclosure — weigh it on postpartum and breastfeeding timing and PCOS and insulin resistance against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.
The bottom line for mothers
Best for: Cost-focused mothers outside its six excluded states who want a price that does not climb as they titrate, and who have read the regulatory record below and are comfortable with it.
Alternatives to Sprout Health
Providers we have a referral relationship with, ordered by their Metabolic-Fit Score — highest first. This module leaves out the provider whose page you are reading, so on CoreAge Rx's own review our #1 pick is the one name you will not find here. These are not the whole roster: see the full ranking for every provider we cover, paid or not.
- Visit CoreAge Rx92
Metabolic-Fit / 100
CoreAge RxOur #1 pickOne flat price, both molecules on a single chart, and a prescriber who reads your history before writing — the most predictable place for a mother to start and, just as important, to pause.
- Visit Gala Health84
Metabolic-Fit / 100
A flat $179 for either molecule with a genuinely gentle microdosing tier — a reasonable, all-doses-included option if you can live with a yearly plan and a pharmacy it doesn't name.
- Visit Enhance MD82
Metabolic-Fit / 100
One of the more oversight-forward compounded programs here — lab work and a live provider visit bundled into a mid-tier flat price, with a gentle microdosing tier — which is exactly what you want when thyroid and hormones are already in flux.
Keep comparing Sprout Health
Head-to-head & alternatives
Sprout Health, answered
- Is Sprout Health's $99 price real?
- It is a first-month rate, not a price. The $99 semaglutide and $149 tirzepatide figures apply to the first month only, on the monthly plan, with a promotional code. The standing price is $299 for compounded semaglutide and $349 for compounded tirzepatide. If you want the low number to persist, the 6-month prepay tier gets semaglutide to $169 a month — but that is six months of commitment paid up front. Budget on $299, not $99.
- Can I actually get Wegovy or Zepbound from Sprout Health?
- No, and this is the most important thing on the page. Sprout's site advertises brand-name Wegovy® and Zepbound® at prices between roughly $1,249 and $1,999, but those products are not purchasable: every call to action resolves to the same compounded-only checkout, and no brand product exists in its catalogue. If an FDA-approved pen is what you want — and for a mother weighing timing around pregnancy, the on-label product with its own labeling is a reasonable thing to want — you will not get one here.
- Does Sprout Health have a regulatory record I should know about?
- Yes, and we would rather you hear it from us. FDA issued Sprout a warning letter on 9 September 2025 (MARCS-CMS 715879) over marketing that described GLP-1 medications as FDA-approved; FDA's index shows no response and no close-out. It also holds a Better Business Bureau rating of F, with 64 complaints on file and 32 of them unanswered. In fairness, the FDA letter concerns how the product was described in marketing rather than a finding about the medication itself — but an unanswered complaint pattern is a reasonable thing to weigh, and both are why it sits where it does in our ranking.
- Which states does Sprout Health serve?
- 44 of them. Its terms publish the list explicitly, which is more than most of this market does. The exclusions are Alabama, Arkansas, California, Louisiana, Mississippi and North Dakota, and the District of Columbia is not included. Worth checking first if you live in one of those — a published list is only useful if you read it before paying.
Pricing, states and verification reflect Sprout Health's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.